Apart from efforts to develop vaccines for Covid-19, 2020 has been a year of substantial advancements in artificial intelligence (AI) and machine learning technologies that are being applied in healthcare as never before, resulting in improvements and enhancements in diagnosis and treatment that were previously impossible.
These technologies are advancing at an increasing rate, and we can be sure that AI will be used even more to overcome healthcare challenges in 2021 and beyond. Here are some of the main areas AI will be used to enhance digital healthcare in the near future.
OncologyMany healthcare practices today, including cancer diagnosis, still rely heavily on manual activities and processes and even those that do utilize digital technologies use them on an independent basis, not under one integral environment. Pathology, the medical specialty of diagnosing disease in patients, most notably cancer, is a good example. Traditional pathology involves manual processes that have remained unchanged for years, where glass slides with tissue samples are analyzed by pathologists using microscopes.
But that is changing today with a growing trend of moving toward digitized infrastructures and workflows (for example digital pathology). This trend is expected to accelerate as a result of the Covid-19 pandemic, increasingly saving time and labor costs while providing better and more cost-effective care. Moreover, adding an AI layer to an already digitized workflow can help make processes even more efficient on several fronts, including:
Triage: AI tools can help determine which cases should be reviewed more urgently and which physicians or resources to assign to them. This will ensure that each case is diagnosed by the physician whose capabilities can best be applied to the situation at hand, assigning cases based on a physicians sub-specialty or level of experience, which becomes especially important in complex cases.
Diagnosis: AI tools can also help with cancer diagnosis and assessment, pointing instantly to particular areas of interest, for instance those that include cancerous cells, and signaling the needle in the haystack factor that can shed light on a patients situation and what may be required to treat them. As a result, turnaround times for case reporting to the referring physician can be reduced significantly. In addition, smart AI tools will allow for the automation of some diagnostic tasks that are currently performed manually, such as counting cells, measuring features and automatically filling up parts of the report.
Next-generation diagnostics: With advanced machine learning capabilities and as more digital datasets become available, AI tools will be able to analyze more data and thus provide more insight than is currently possible. These tools will go beyond mimicking a physicians diagnosis; AI models will integrate extensive amounts of data from diverse sources (e.g., imaging, pathology and clinical data), acting as a sort of tumor board, where experts from multiple fields share their findings and knowledge to decide on the most accurate diagnosis and treatment. In the near future, we can expect to see AI serve as the perfect companion to the physician, with an unparalleled ability to combine huge amounts of fragmented information accurately and effectively.
Telehealth and Physician AccessThe need for quality healthcare keeps growing with an aging population and an increase in disease incidence. The number of physicians, however, does not grow at the same rate, and this creates a supply gap particularly evident for certain medical sub-specialties, in far-flung rural communities and sometimes even in urban centers. AI-based telehealth for instance, a new generation of affordable and accurate sensing devices that can be used to examine, monitor or diagnose patients remotely, as well as new communication technologies such as AI-based chatbots will help transform a visit to the doctors office into a completely different experience, enabling a more effective, frequent and affordable physician access for patients. The pandemic, with its frequent quarantines and regional lockdowns, only demonstrated the importance of these technologies as well as the shift needed in the mindset of all stakeholders: patients, physicians, providers and payers.
Personalized MedicineWith all the advancements in medical science, prognostic assessments and treatment decisions are many times not much better than a shot in the dark. For example, up to 75% of oncology patients (in a number of cancer types) do not respond to at least one of the available treatment drugs. Developing new biomarkers and genomic tests to more accurately predict prognosis and enable physicians to choose the right treatment is a costly, unpredictable, and painfully slow process.
Enter AI. Biomarkers based on artificial intelligence and machine learning can be an important, cost-effective and efficient way to develop tools for precision medicine. AI algorithms could provide new prognostic insights and help oncologists stratify patients into smaller, more homogeneous groups and assist in selecting personalized treatment for each patient based on a multitude of data types. These algorithms will combine pathology, radiology, genomic, clinical and demographic data, and analyze huge databases of medical records, treatments and outcomes. AI-driven solutions could also provide a more accurate and objective analysis of medical data, leading to new computational tests that replace or augment todays molecular tests.
Quality ControlObviously an essential part of any quality-driven system, quality control is a real challenge in labor-intensive processes. For example, for pathologists diagnosing cancer, an effective near bulletproof quality control requires having a second pathologist review the same biopsy again a time consuming and costly task. As a result, we find many clinical processes where quality control is done only on a small fraction of cases, if at all, often failing to detect errors.
AI and advanced algorithms can help create concurrent processes that rapidly review medical procedures and diagnoses, detecting mistakes early enough to avoid any damage. Fast and automated AI tools will enable pathology labs for the first time to apply rigid quality control standards to all their cases. Currently, the majority of cases are viewed by a single pathologist in almost all labs, which means that errors and misdiagnosed cancers may not be detected on time. AI can help transform this completely.
Algorithms can also alert on inconsistent findings, making sure the different medical disciplines provide a coherent picture of the patients condition and treatment plan, and that there are no holes in the process. An electronic medical record (EMR) that contains all the medical information of a patient could be constantly monitored by AI whenever something suspicious is detected, such as a lab test result that is inconsistent with a previous diagnosis, or a drug prescription that does not match the patients condition, the AI would highlight the inconsistency, prompting a thorough review by the relevant physician.
Screening ProtocolsDecisions on issues like which patient should be sent for a specific test CT, MRI, colonoscopy and others are currently conducted based on demographics or other general variables that often have nothing to do with a patients medical record. Going forward, we will see more medical screening thats based on specific characteristics identified by AI algorithms trained on large providers datasets. Such predictive algorithms will identify specific patterns, risk factors or correlations between multiple variables using advanced machine learning techniques.
Science-based medicine is one of the miracles of the modern age; lives are being saved today that just a few years ago would have been unsalvageable, and new, advanced treatments are providing a much better quality of life for many more than would have been possible in the past. Still, there are many domains in medicine and healthcare that could benefit from adopting the latest developments in artificial intelligence and machine learning and we see their role in improving healthcare becoming ever more important in the future.
More:
Predictions for AI-powered digital healthcare in 2021 - MedCity News
- Personalized medicine: The pros, cons and concerns - New Atlas - November 16th, 2024
- Precision Medicine, AI, and the Future of Personalized Health Care - November 16th, 2024
- Why precision medicine results in more effective health care, treatment plans - The Business Journals - November 16th, 2024
- Comprehensive Genomic Profiling at Diagnosis Extends Survival in Patients with Advanced Cancer - Inside Precision Medicine - November 16th, 2024
- More Precise Classifications of NonClear Cell RCC Are Required to Improve Personalized Treatment - OncLive - September 13th, 2024
- Bahrain aims to provide residents with personalized healthcare - Healthcare IT News - September 13th, 2024
- Precision Medicine Market Is Expected To Reach Revenue Of - GlobeNewswire - September 13th, 2024
- New Graduates Leverage Genomics Education in Clinical and Research Settings - University of Colorado Anschutz Medical Campus - June 20th, 2024
- Personalized medicine is coming, but who will have access to it? - March 10th, 2024
- Personalized medicine | Definition, Origins, Examples, & Ethical ... - March 10th, 2024
- Innovating for Individual Care: The Impact of USP on Personalized Medicine - March 10th, 2024
- Live Cell Encapsulation Market To Reach USD 313.3 Million at a CAGR of 4% in 2032 - EIN News - April 23rd, 2023
- Cancer Therapeutics and Biotherapeutics Market is estimated to be US$ 506.8 billion by 2032 with a CAGR of - EIN News - April 7th, 2023
- Regenerative Therapies Market is Set to Grow at a CAGR of 8.7% by 2033, Propelled by Advancements in - EIN News - March 13th, 2023
- Gene Therapy Market Size (USD 46.5 Bn by 2030): A Growing Industry and Its Impact on Healthcare Systems - EIN News - March 13th, 2023
- Translating the Microbiome - Inside Precision Medicine - October 15th, 2022
- Enhancing Enrollment in Biomarker-Driven Oncology and Rare Disease Trials - Applied Clinical Trials Online - October 15th, 2022
- Global Cancer/Tumor Profiling Market Research Report to 2027 - Increasing Demand for Personalized Medicine Presents Opportunities -... - October 15th, 2022
- Cambridge biotech raises $168 million to fight cancer and other diseases - The Boston Globe - October 15th, 2022
- Perlmutter Cancer Center Medical Oncologist Provides Personalized Care to People with Breast Cancer - NYU Langone Health - October 15th, 2022
- Concierge Medicine's Continued Rise Illuminated by Specialdocs Consultants at the Industry's Leading Event - PR Newswire - October 15th, 2022
- Hormone Changes: The Star of Every Stage in Women's Sleep - Medscape - October 15th, 2022
- Could Xolair Be the First Biologic Treatment for Food Allergies? - Allergic Living - October 15th, 2022
- Matching Treatments to Your Genes - The Epoch Times - October 15th, 2022
- Global Monoclonal Antibodies (mAbs) Markets, 2018-2021 & 2022-2030 - Increasing R&D Activities Aimed at the Development of Novel Therapeutic mAbs -... - October 15th, 2022
- Xcell Biosciences and aCGT Vector Collaborate to Accelerate Development of Cell and Gene Therapies - Business Wire - October 15th, 2022
- Learn Look Locate Partners with Genetic Testing Leader, Myriad Genetics, in Educational Campaign - PR Newswire - October 15th, 2022
- Important Mission By LG To Reinvent Society With Future Growth - Forbes - October 15th, 2022
- Scientists identify more than 12,000 spots in the human genome associated with height - Inverse - October 15th, 2022
- The future of cancer research | News - ND Newswire - October 15th, 2022
- Kyverna Therapeutics Names Peter Maag, Ph.D., as Chief Executive Officer - PR Newswire - October 15th, 2022
- Call for Accurate Automation in Healthcare Practices to drive the Laboratory Information Systems (LIS) Market | Future Market Insights, Inc. - Yahoo... - October 15th, 2022
- Stem Cell Manufacturing Global Market Report 2022: Widespread Product Utilization in Effective Disease Ma - Benzinga - October 15th, 2022
- Global Precision Medicine Software Market is projected to witness a healthy growth rate of 10% in the upcoming years - Bio-IT World - July 17th, 2022
- The Single-Cell Analysis Market Size To Almost Double By 2026 Due To A Rising Focus On Personalized Medicine As Per The Business Research Company's... - July 17th, 2022
- Northwell Health Partners with Google Cloud to Provide Proactive, Personalized Healthcare - PR Newswire - July 17th, 2022
- Leveraging whole blood based functional flow cytometry assays to open new perspectives for rheumatoid arthritis translational research | Scientific... - July 17th, 2022
- New Approaches Needed To Support Digitization Of Healthcare - Forbes - July 17th, 2022
- Outlook on the Microtome Global Market to 2027 - Increasing Demand for Personalized Medicine Presents Opp - Benzinga - July 17th, 2022
- Precision health perspectives - UCI News - July 17th, 2022
- The Worldwide Compound Management Industry is Expected to Reach $1.4 Billion by 2030 - ResearchAndMarkets.com - Business Wire - July 17th, 2022
- Thrive Pet Healthcare and FidoCure Announce An Expansive Pet Precision Health Partnership - Benzinga - Benzinga - July 17th, 2022
- Access to Myriad Genetics GeneSight Test Improves Depression Remission Rates In Largest Ever Mental Health PGx Randomized Controlled Trial - Yahoo... - July 17th, 2022
- Global Induced Pluripotent Stem Cell (iPSC) Market Report 2022: Rising Applications of iPSCs Fueling Industry Growth - ResearchAndMarkets.com -... - July 17th, 2022
- Research Antibodies and Reagents Market worth $16.1 Billion by 2027 Exclusive Report by MarketsandMarkets - Yahoo Finance - July 17th, 2022
- Global Custom Antibody Market Is Expected To Reach USD 742.27 Million At A CAGR Of 10.3% And Forecast To 2029 - Digital Journal - July 17th, 2022
- Personalized Medicine Coalition - Precision Medicine Advocacy and ... - June 8th, 2022
- Precision Medicine | FDA - June 8th, 2022
- Global Precision Medicine Software Market is anticipated to witness a lucrative CAGR of 10% - GlobeNewswire - June 8th, 2022
- Global Biomarkers Markets Research 2022-2027: Increased Adoption of Biomarkers in Personalized Medicine / Focus on Digital Biomarkers / Increased... - June 8th, 2022
- Every patient in this experimental drug trial saw their cancer disappear, researchers say - CBS News - June 8th, 2022
- The Middle East molecular diagnostics market is projected to reach $1,017.7 million by 2031 from $493.1 million in 2020, at a CAGR of 6.72% during the... - June 8th, 2022
- It's time to move past Aduhelm and focus on a broader Alzheimer's drug pipeline - STAT - June 8th, 2022
- Can the industry elevate the success rate of cancer trials? - OutSourcing-Pharma.com - June 8th, 2022
- Purdue Polytechnic Institute and Purdue University Global collaborating on partnership with the University of Puerto Rico - Purdue University - June 8th, 2022
- Illumina Announces Next Generation Products and Data at AGBT General Meeting to Advance Innovative Customer Solutions - PR Newswire - June 8th, 2022
- AdhereTech and Massive Bio, Two of NYC Digital Health 100 most Promising Start-Ups, Announce AI-Enabled, Patient-Centric Oncology Solutions... - June 8th, 2022
- Time to Rethink Metformin as First-Line Therapy? Perspective from ADA 2022 - Endocrinology Network - June 8th, 2022
- PreludeDx Presents New DCISionRT Data on the Effectiveness of Endocrine Therapy in DCIS Patients at the ASCO 2022 Annual Meeting - 69News WFMZ-TV - June 8th, 2022
- BITS Pilani Hyderabad to conduct 'Precision Medicine 2022' event tomorrow - United News of India - June 8th, 2022
- Global Laboratory Information Systems (LIS) Market to Reach US$2.4 Billion by the Year 2026 - Yahoo Finance - June 8th, 2022
- Medical Nutrition Market Promising Growth Opportunities and Forecast 2027 - Digital Journal - June 8th, 2022
- 57% of Organizations in India are at the Startup Stage of Genomics High-Performance Computing Infrastructure - APN News - June 8th, 2022
- Cellworks Singula TRI Provides Personalized OS and PFS Predictions for 18 NCCN Guideline GBM Therapies - StreetInsider.com - June 8th, 2022
- Inspiration for the laboratory of tomorrow - Chemie.de - June 8th, 2022
- Global Nanomaterials in Personalized Medicine Market (Impact Of COVID-19) Growth, Overview With Detailed Analysis 2022-2028 Queen Anne and Mangolia... - May 8th, 2022
- The global biomarkers market is expected to grow at a CAGR of 11.44%. - Yahoo Finance - May 8th, 2022
- Bioinformatics Market Size, Share, And Trends Analysis Report, By Application (Drug Development, Protein Function Analysis, Gene Therapy, Molecular... - May 8th, 2022
- Link between EBV and MS may give clues to the cause of long COVID - The Arizona Republic - May 8th, 2022
- Improving Cell Cultures with Thermoresponsive Coatings - Genetic Engineering & Biotechnology News - May 8th, 2022
- Reevaluating, Reimagining, And Reinventing Healthcare: Innovation In A Post-Pandemic World - Forbes - May 8th, 2022
- Study of Cancer Genetics to Help with Targeted Treatment - VOA Learning English - May 8th, 2022
- Increased demand for Molecular diagnostics after the COVID-19 outbreak - The Financial Express - May 8th, 2022
- CIOs' 5-year plans for precision medicine and emerging technologies - Healthcare IT News - January 30th, 2022
- SeqOne Genomics Closes 20M Series a to Accelerate the Deployment of Its Genomic Medicine Platform - Business Wire - January 30th, 2022
- Study: In IBS patients, cognitive behavioral therapy modulates the brain-gut microbiome and helps relieve symptoms - UB News Center - January 30th, 2022
- (New Report) Digital Genome Market In 2022 : The Increasing use in Diagnostics, Agriculture & Animal Research, Personalized Medicine, Drug... - January 30th, 2022
- Silencing a faulty gene may uncover clues to rare forms of ALS - National Institutes of Health - January 30th, 2022
- Plants, Bioprinting and Orbital Plumbing Fill Crew's Thursday Schedule - NASA - January 30th, 2022
- ClarityX DNA: The Key to Tackling Seasonal Affective Disorder - PR Web - January 30th, 2022